EDDIT: Early Drug Discovery for Targeted Protein Degradation
First in Class Ferroptosis Inhibitors: For Preventative Treatment of Delayed Graft Function in Kidney Transplantation and other Ferroptosis-related indications
CAR-mast Cell Therapy for Solid Tumors
curIOS Therapeutics: mRNA therapies targeting the driver antigens in virus-associated cancers
Small molecule and enzymatic approaches to revert aberrant phase transitions in neurological disorders
Advancing a non-hallucinogenic psychedelic drug combination
